Physician profile
Joseph E Dove
NPI 1114116498
$1,070.61
in general payments reported to CMS, 2019-2025
14 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $186 · 2022: $231 · 2023: $157 · 2024: $291 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637 · Travel and Lodging: $16.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.13 |
| Travel and Lodging | $16.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $454.24 | 2022-2025 | Simplimax, Puraply Franchise, Via Matrix |
| Paratek Pharmaceuticals, INC. | $149.04 | 2021-2024 | Nuzyra |
| Nevro Corp. | $103.28 | 2023-2024 | Senza |
| Smith+Nephew, INC. | $84.08 | 2021-2024 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Nabriva Therapeutics, Plc | $77.70 | 2021-2022 | |
| Tactile Systems Technology INC | $43.54 | 2025 | Nimbl, Flexitouch Plus |
| Biocomposites INC | $22.94 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.78 | 2021 | |
| Kerecis Limited | $22.48 | 2022 | |
| Heron Therapeutics, INC. | $20.30 | 2021 | |
| Hartmann USA, INC. | $18.98 | 2021 | |
| Horizon Therapeutics Plc | $18.11 | 2022 | |
| Convatec INC. | $17.09 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $16.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Dove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.